VAS
PFE icon

Vestmark Advisory Solutions’s Pfizer PFE Stock Holding History

Vestmark Advisory Solutions’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.08M Buy
335,343
+17,237
+5% +$451K 0.08% 277
2026
Q1 		$8.93M Buy
318,106
+276,646
+667% +$7.37M 0.1% 211
2025
Q4 		$1.03M Buy
41,460
+21,660
+109% +$546K 0.01% 784
2025
Q3 		$504K Buy
+19,800
New +$489K 0.01% 698
2025
Q2 		– Sell
-18,724
Closed -$474K – 803
2025
Q1 		$474K Buy
+18,724
New +$490K 0.01% 523
2024
Q4 		– Sell
-8,878
Closed -$257K – 603
2024
Q3 		$257K Buy
+8,878
New +$259K 0.01% 484
2023
Q4 		– Sell
-37,292
Closed -$1.24M – 526
2023
Q3 		$1.24M Sell
37,292
-157,193
-81% -$5.56M 0.09% 220
2023
Q2 		$7.13M Sell
194,485
-2,578
-1% -$100K 0.27% 87
2023
Q1 		$8.04M Buy
197,063
+10,194
+5% +$440K 0.35% 56
2022
Q4 		$9.58M Buy
186,869
+6,529
+4% +$313K 0.47% 38
2022
Q3 		$7.89M Buy
180,340
+21,757
+14% +$1.06M 0.44% 41
2022
Q2 		$8.31M Buy
158,583
+32,271
+26% +$1.64M 0.47% 34
2022
Q1 		$6.54M Buy
126,312
+4,304
+4% +$223K 0.37% 50
2021
Q4 		$7.21M Buy
122,008
+1,510
+1% +$74.8K 0.41% 44
2021
Q3 		$5.18M Buy
120,498
+10,565
+10% +$468K 0.35% 63
2021
Q2 		$4.3M Sell
109,933
-5,046
-4% -$196K 0.31% 73
2021
Q1 		$4.17M Sell
114,979
-14
-0% -$497 0.37% 60
2020
Q4 		$4.23M Sell
114,993
-2,290
-2% -$84K 0.48% 44
2020
Q3 		$4.08M Sell
117,283
-16,033
-12% -$562K 0.55% 33
2020
Q2 		$4.14M Sell
133,316
-45,684
-26% -$1.55M 0.64% 29
2020
Q1 		$5.54M Buy
179,000
+7,473
+4% +$255K 1.08% 13
2019
Q4 		$6.38M Buy
171,527
+5,783
+3% +$206K 1.31% 13
2019
Q3 		$5.65M Buy
165,744
+13,708
+9% +$498K 0.92% 15
2019
Q2 		$6.25M Sell
152,036
-13,960
-8% -$554K 1.07% 10
2019
Q1 		$6.69M Buy
+165,996
New +$6.65M 1.19% 7

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Vestmark Advisory Solutions's PFE Position: Q2 2026 in Review

Vestmark Advisory Solutions increased its Pfizer (PFE) stake by 5.4% in Q2 2026, buying an estimated $451K and bringing the position to 335,343 shares worth $8.08M. The position accounts for 0.08% of the portfolio, ranked #277.

Vestmark Advisory Solutions first reported a position in PFE in Q1 2019 and has held it in 25 quarters since. The position peaked at $9.58M in Q4 2022. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Vestmark Advisory Solutions held 335,343 shares of Pfizer worth $8.08M as of Q2 2026.
  • Vestmark Advisory Solutions bought 17,237 Pfizer shares in Q2 2026, an estimated $451K.
  • Pfizer made up 0.08% of Vestmark Advisory Solutions's portfolio in Q2 2026, its #277 holding.
  • Vestmark Advisory Solutions first reported a position in Pfizer in Q1 2019 and has held it in 25 quarters since.
  • Vestmark Advisory Solutions's Pfizer position peaked at $9.58M in Q4 2022.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Vestmark Advisory Solutions's 13F filing for Q2 2026, filed 14 Aug 2026.